95 results
Page 3 of 5
8-K
p15fdvxx kc
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
dkfg6q0bk3 f6rl
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-4.2
8tj7cfh9n7d
8 May 20
Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
4:40pm
8-K
EX-4.2
88l eiyly66j7i
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
ewhqt06s o13
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
d6xvxa
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
x72g jpe137
13 Dec 19
Prospectus supplement for primary offering
7:59am
424B4
m64847u4wvy7z
15 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
ele4o 51i4iptkq5l112
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.4
omylnykrs td0
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-4.2
0vf2x1cp5t
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm
8-K
EX-10.2
nkuaybnjxcfv
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm